The 6 best at a glance
| Rank | Provider | Best for | Free consult? |
|---|---|---|---|
| #1 | GobyMeds | First-time telehealth-GLP-1 patients | Yes |
| #2 | Brightmeds | Subscription simplicity | Bundled into first month |
| #3 | Henry Meds | Longest operating history | No (paid intake) |
| #4 | Direct Meds | Lowest published price | No (paid intake) |
| #5 | Mochi Health | Clinical-team bundled support | No (paid intake) |
| #6 | Regenics | Wellness-clinic format | No (paid intake) |
How we ranked them
This ranking is based on five factors weighted by reader feedback we've collected since 2024:
- Pharmacy partner verification — state-licensed 503A pharmacies, US shipping only
- Pricing transparency— published on the provider's website before intake, not buried behind pressure calls
- Clinician responsiveness — time to first review, communication quality after intake
- State coverage — broader is better; some smaller providers only cover 20–30 states
- Switching friction — reasonable refund/cancellation policies; no auto-renewal traps
Pricing tier is part of the picture but not the only factor — the lowest-priced provider isn't automatically #1 because pricing volatility, clinician availability, and pharmacy reliability matter more for ongoing therapy than $10–20/month savings.
#1 GobyMeds — Best Overall (Free Consult)
GobyMeds is our top pick on the strength of the free initial consultation. Patients can complete intake, get clinician review, and confirm eligibility before paying anything. Few peers offer this. State-licensed 503A pharmacy partners, US clinician network, transparent monthly pricing.
Best fit: cash-pay patients new to telehealth-GLP-1 who want to confirm eligibility risk-free, or patients comparing multiple providers who don't want to pay multiple intake fees.
Full review: GobyMeds independent review →
#2 Brightmeds — Best for Subscription Simplicity
Brightmeds runs a clean monthly subscription with intake-fee bundling, broad state coverage, and competitive mid-market pricing. State-licensed 503A pharmacy partners, US clinician network. The subscription model means predictable monthly cost without separate intake/refill fees.
Best fit: patients who want a simple monthly bill rather than à la carte intake + medication pricing. Strong choice for ongoing therapy once you're past the initial-eligibility question.
Full review: Brightmeds independent review →
#3 Henry Meds — Longest Operating History
Henry Meds has been in the compounded-GLP-1 space since 2022 — longer than most peers. Broad clinician network, broad state coverage, mid-market pricing tier. Tracks intake feedback systematically and has more publicly available outcome data than newer entrants.
Best fit: patients who weight operating history heavily, or patients in states where smaller providers don't ship.
#4 Direct Meds — Lowest Published Price
Direct Meds runs the lowest published compounded tirzepatide rate in our portfolio review (recently $179/month, subject to change). Strong choice on pure pricing. Less brand polish than larger peers; service-pacing complaints during demand spikes have shown up in reader feedback.
Best fit: price-sensitive patients comfortable with a less polished UX in exchange for the lowest published rate.
#5 Mochi Health — Best for Bundled Clinical Support
Mochi Health pairs compounded GLP-1 with broader clinical support — nutritionist access, weekly weigh-ins, support team. Higher monthly pricing than peers, justified for patients who want the wraparound support. Less right for patients who just need the medication.
Best fit: first-time weight-management patients who want clinical accountability bundled into the program, not just the prescription.
#6 Regenics — Wellness-Clinic Format
Regenics operates more as a wellness clinic with GLP-1 as part of a broader peptide/hormone portfolio. Higher-touch model, higher pricing, broader medical-services menu (TRT, peptide therapy, NAD+). Less right for patients who just want compounded GLP-1, more right for patients exploring multiple wellness protocols.
Best fit: patients combining GLP-1 with other treatments (TRT, peptide therapy) who prefer a single clinic relationship.
Which one is right for you?
| If you... | Start with |
|---|---|
| ...are new to telehealth-GLP-1 and want to confirm eligibility risk-free | GobyMeds (free consult) |
| ...want predictable monthly subscription pricing | Brightmeds |
| ...prioritize provider operating history | Henry Meds |
| ...want absolute lowest published price | Direct Meds |
| ...want bundled clinical support | Mochi Health |
| ...are stacking GLP-1 with TRT or peptide therapy | Regenics |
What you should NOT do
- Don't buy compounded GLP-1 from offshore pharmacies. Any provider shipping from outside the US is operating illegally and has no quality oversight.
- Don't buy “research-only” or “not for human consumption” semaglutide or tirzepatide from peptide vendors. Not the same product, no clinician oversight, no sterility guarantees.
- Don't skip the clinician review. Compounded GLP-1 has the same contraindications as brand-name (MTC history, MEN 2, severe pancreatitis history, active eating disorder, pregnancy) and clinician oversight matters.
- Don't default to compounded if your insurance covers brand at $25/month. The savings card is dramatically cheaper than any compounded program.
Frequently asked questions
Are compounded GLP-1 medications legal?
Yes, when prepared by a state-licensed 503A pharmacy under a valid prescription. Compounding is permitted under section 503A of the Federal Food, Drug, and Cosmetic Act when (a) the pharmacy is registered and inspected by a state board of pharmacy, (b) compounding addresses a specific patient need, and (c) the medication is dispensed pursuant to a prescription. Compounded GLP-1 medications are not FDA pre-market approved (that's different from being illegal) — they're individually compounded preparations operating within established US pharmacy regulations.
How is compounded tirzepatide different from Zepbound?
The active ingredient is identical — tirzepatide is tirzepatide whether it's in branded Zepbound or compounded form. The differences are: (1) Zepbound is manufactured by Eli Lilly with FDA pre-market approval and full clinical-trial backing; compounded versions are prepared individually by 503A pharmacies under separate regulatory conditions. (2) Brand Zepbound comes in standardized prefilled pens or vials; compounded preparations may be vials, multi-dose vials, or oral troches depending on the pharmacy. (3) Cost: Zepbound retail $1,059/month; compounded versions typically $150–$200/month through telehealth.
Why is compounded GLP-1 so much cheaper than brand?
Brand-name Zepbound and Wegovy carry the costs of clinical trial development, FDA approval, mass manufacturing, marketing, and Lilly/Novo's profit margins. Compounded versions are prepared in smaller batches at 503A pharmacies that don't carry those costs and aren't paying for brand marketing. The pharmacies do pay licensing fees, state inspection costs, and pharmaceutical-grade ingredient sourcing, but the total cost structure is dramatically lower than brand-name pharmaceutical manufacturing.
What should I look for in a compounded GLP-1 provider?
Five things: (1) state-licensed 503A pharmacy partners — verify the pharmacy is licensed in your state, (2) US-licensed prescribing clinicians, (3) transparent published pricing on the website (not pressure-sale tactics), (4) US shipping only (no offshore products), (5) clear policies on refunds, switching, and side-effect management. Reputable providers publish all of this on their site before you complete intake.
Can my insurance cover compounded GLP-1?
Generally no — most US insurance plans only cover FDA pre-market approved medications. Compounded preparations are typically outside the insurance reimbursement framework. HSA and FSA funds are usually eligible since compounded medications are a qualified medical expense — check with your HSA/FSA administrator. If you have commercial insurance that covers brand Zepbound or Wegovy and you qualify for the manufacturer savings card ($25/month), that's almost always the cheaper path.
What if the FDA changes the rules on compounding?
FDA has taken intermittent action on GLP-1 compounding since 2023. In late 2024, FDA removed semaglutide from the official drug-shortage list, which had been the regulatory basis for some compounded semaglutide. Most compounding pharmacies shifted to compounding tirzepatide, which remained on the shortage list longer. Future rule changes are possible — choose providers with multiple pharmacy partners and demonstrated ability to adapt to regulatory shifts.
Which is better — compounded semaglutide or compounded tirzepatide?
Same answer as for brand-name: tirzepatide produces more average weight loss (~20% vs ~14% in 72-week trials) with comparable side-effect profiles. Tirzepatide is also cheaper across most cost paths in 2026. For patients without specific reasons to prefer semaglutide (established cardiovascular disease, prior tolerance, oral preference), compounded tirzepatide is the better starting choice. Most providers in this roundup offer both.
How fast can I start on a compounded GLP-1 program?
From intake to first shipment: typically 5–10 days for new patients. Intake is completed online (8–12 minutes), clinician review takes 24–72 hours, prescription is sent to the partner pharmacy, and shipping is 3–7 business days. Refill shipping for established patients is faster (1–3 business days from auto-refill date). Providers with same-day clinician review can compress the front-end timeline.
Editor's bottom line
For most cash-pay patients new to telehealth-GLP-1, start with GobyMeds' free consult— it's the lowest-risk entry into the category. If you prefer predictable subscription pricing, Brightmeds is our #2. Either is a credible choice for ongoing therapy. If your commercial insurance covers brand Zepbound or Wegovy at $25/month, ignore compounded entirely and take the savings card path. Compounded GLP-1 is for patients without insurance coverage, not for patients who already have it.